Progyny, Inc. financials

  1. Home
  2. Financials
  3. PGNY
PGNY CIK 0001551306

Source: EDGAR filings · Built 2026-06-02T03:49:11Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 191.78M 173.70M 185.17M 77.15M 23.91M 35.17M
EBITDA 90.22M 70.63M 64.47M 24.94M 33.64M 10.25M
Working Capital 349.38M 304.09M 454.46M 274.32M 159.72M 112.44M
Net Debt -84.51M -143.04M -77.91M -112.36M -82.76M -60.76M
Gross Margin 23.63% 21.71% 21.94% 21.26% 22.40% 20.32%
Operating Margin 6.62% 5.78% 5.71% 2.97% 6.46% 2.42%
Net Margin 4.54% 4.66% 5.70% 3.86% 13.14% 13.47%
Return on Equity (ROE) 11.34% 12.87% 11.21% 8.05% 26.12% 27.83%
Return on Assets (ROA) 7.88% 8.95% 8.20% 5.59% 18.37% 18.30%
Current Ratio 2.73× 2.80× 3.44× 2.72× 2.62× 2.45×
Debt-to-Equity 0.05× 0.05× 0.04× 0.02× 0.03× 0.06×
Effective Tax Rate 38.68% 34.69% 12.24% -24.21% -102.77% -435.30%
Cash Conversion Ratio 3.59× 3.30× 3.04× 2.65× 0.40× 0.78×
Accruals Ratio -0.20× -0.21× -0.17× -0.09× 0.11× 0.04×
SBC % of Revenue 10.23% 10.98% 11.26% 12.80% 6.73% 3.72%
CapEx Coverage 11.42× 33.14× 51.81× 24.81× 12.23× 34.91×
Free Cash Flow Per Share $2.13 $1.82 $1.84 $0.77 $0.24 $0.35

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 39.51× 30.26× 59.97× 103.83× 76.29× 90.19×
P/FCF 12.03× 9.48× 20.21× 40.35× 211.38× 119.41×
FCF Yield 8.31% 10.55% 4.95% 2.48% 0.47% 0.84%
EV / EBITDA 22.79× 18.81× 54.36× 112.02× 133.87× 353.96×
P/S 1.66× 1.26× 3.29× 3.69× 9.16× 10.70×
P/B 4.15× 3.49× 6.47× 7.71× 18.21× 22.10×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 1.29B 1.17B 1.09B 786.91M 500.62M 344.86M
Cost of Goods and Services Sold 984.18M 913.86M 849.80M 619.59M 388.49M 274.80M
Gross Profit 304.48M 253.36M 238.80M 167.32M 112.14M 70.06M
Research and Development Expense 9.50M — — — — —
Operating Expenses 219.21M 185.91M 176.62M 143.98M 79.80M 61.71M
Operating Income (Loss) 85.28M 67.45M 62.18M 23.34M 32.34M 8.35M
Income Tax Expense (Benefit) 36.91M 28.87M 8.65M -5.92M -33.33M -37.78M
Net Income (Loss) Attributable to Parent 58.52M 54.34M 62.04M 30.36M 65.77M 46.46M
Earnings Per Share, Basic $0.68 $0.59 $0.65 $0.33 $0.74 $0.54
Weighted Average Number of Shares Outstanding, Basic 85.65M 91.48M 95.02M 92.20M 89.11M 85.72M
Earnings Per Share, Diluted $0.65 $0.57 $0.62 $0.30 $0.66 $0.47
Weighted Average Number of Shares Outstanding, Diluted 89.86M 95.45M 100.67M 99.96M 100.36M 99.06M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 112.24M 162.31M 97.30M 120.08M 91.41M 70.31M
Assets, Current 551.77M 472.72M 640.41M 433.86M 258.54M 190.22M
Assets 742.43M 607.10M 756.62M 542.99M 358.06M 253.93M
Liabilities, Current 202.39M 168.63M 185.95M 159.54M 98.82M 77.79M
Liabilities 226.39M 185.04M 203.19M 166.02M 106.24M 86.98M
Stockholders' Equity Attributable to Parent 516.04M 422.06M 553.43M 376.97M 251.82M 166.95M
Common Stock, Shares, Outstanding 83.37M 85.31M 96.35M 93.30M 91.09M 87.05M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 210.19M 179.10M 188.81M 80.39M 26.04M 36.20M
Payments to Acquire Property, Plant, and Equipment 18.41M 5.41M 3.64M 3.24M 2.13M 1.04M
Net Cash Provided by (Used in) Investing Activities -159.01M 195.79M -200.53M -43.87M 8.77M -40.03M
Payments for Repurchase of Common Stock 81.66M 300.28M 0 0 — —
Net Cash Provided by (Used in) Financing Activities -99.36M -309.88M -11.07M -7.86M -13.70M -6.25M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (PGNY CIK 0001551306), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

AVAH

Aveanna Healthcare Holdings Inc.

HNRG

HALLADOR ENERGY CO

RGNX

REGENXBIO Inc.